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Background: Recovery of cardiac function after cardiac surgery and other
interventional cardiac procedures in elderly patients is inferior to that in
younger patients, suggesting that the aged myocardium is more sensitive to
ischemia and other stresses. Although convincing data from animal studies
of senescence now exist, there is a dearth of controlled in vitro studies that
examine the specific response of aged human myocardium to the stress of
hypoxia or ischemia.
Objective: We sought to determine the effect of age on the capacity of human
atrial trabeculae to recover contractile function after in vitro hypoxic or
ischemic stress.
Methods: Atrial pectinate trabeculae were dissected from the tip of 58 right
atrial appendages harvested during an operation in patients aged between 34
and 89 years and electrically stimulated at 1 Hz in oxygenated Ringer’s solu-
tion at 37°C. Tissues experienced 30 minutes of either hypoxia (N2 and per-
fusate) or simulated ischemia (humidified N2 without perfusate) and were
returned to normoxia for recovery of function for 30 minutes. Developed
force and other contractile variables were determined during each period.
Results: Under normoxic conditions, no significant age difference was
observed for any contractile function variable. However, after hypoxia, the
old (70-89 years) and intermediate age groups (60-69 years) showed reduced
recovery of developed force (48.5% ± 22.2% [n = 11] and 44.9% ± 19% [n
= 12], respectively) compared with that found (66.4% ± 19.7% [n = 15]) in
the younger (34-59 years) group (mean ± SD, P = .02). Similarly, after sim-
ulated ischemia, the groups of 70- to 89-year-old and 60- to 69-year-old sub-
jects showed reduced recovery of developed force (35.7% ± 17% [n = 5] and
51.1% ± 11.8% [n = 9], respectively) compared with that found (68.2% ±
10.4% [n = 6]) in the group of 34- to 59-year-old subjects (P = .01).
Multivariable analysis, comparing 20 factors of surgical patient characteris-
tics and recovery of developed force, found that only age (P = .01) and
hypertension (P = .01) were predictors of reduced recovery of developed
force after either hypoxia or simulated ischemia.
Conclusions: In aged human atrial myocardium, the capacity to recover contrac-
tile function after in vitro hypoxia or simulated ischemia is reduced compared
with the younger myocardium of mature adults. These findings suggest that
enhanced myocardial protective strategies may be indicated for elderly patients
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Despite continuing improvements in operative tech-nique and myocardial preservation strategy, age
remains a major risk factor for mortality and postoper-
ative morbidity for all forms of cardiac surgery.1,2
Similarly, for coronary angioplasty the risk of proce-
dural mortality and postprocedural myocardial infarc-
tion is increased in elderly patients.3 Evidence that
these age-associated differences may have a myocar-
dial basis is provided by studies of sheep,4 rats,5 and
rabbits,6 which show markedly reduced recovery of
contractile function after ischemia in aged hearts com-
pared with younger hearts. Despite protection with car-
dioplegia, aged animal hearts manifest poor recovery
after reperfusion compared with their younger counter-
parts.7 Even aerobic pacing stress in isolated working
rat hearts evokes a meager post-stress recovery of per-
formance from aged compared with young hearts.8
Although distinct differences in myocardial function
between aged and young adults have been described in
animal models,9-11 there is a dearth of direct examina-
tion of the influence of age on postischemic or posthy-
poxic recovery of human myocardial contractile func-
tion. Although various controlled stresses can be
readily generated in senescent myocardium in animals
and the response can be accurately quantified, this is
not readily achievable in human subjects. The aim of
this study was to directly examine, under controlled
conditions, whether age-associated differences are evi-
dent in the recovery of contractile function in human
atrial myocardium after exposure to hypoxia or
ischemia in vitro.
Methods
Isolated human atrial pectinate muscle preparation.
Patients undergoing a non-emergency coronary artery bypass
graft operation and free of overt right heart failure were used
in this study. The tip of the right atrial appendage was rou-
tinely excised and discarded to facilitate placement of a
venous cannula in the right atrium. Approval to use the right
atrial appendage was granted by the Alfred Hospital Ethics
Committee. The right atrial appendage was placed in ice-cold
modified Ringer’s solution containing the following: 2,3-
butanedione monoxime, 30 mmol/L; NaCl, 125.8 mmol/L;
KCl, 3.6 mmol/L; MgSO4, 0.6 mmol/L; NaH2PO4, 1.3
mmol/L; NaHCO3, 25.0 mmol/L; glucose, 11.2 mmol/L; and
CaCl2, 2.5 mmol/L. Pectinate muscles from the right atrial
appendage, viewed with a dissection microscope, were
excised while superfused with modified Ringer’s solution
(95% O2/5% CO2, pH 7.4) and cut into strips (length, >3 mm;
diameter, <1 mm).
Individual muscle strips were connected to a Grass FT03
force transducer (Grass Instrument Division, West Warwick,
RI) and held between two platinum field-stimulation elec-
trodes (normoxia and hypoxia). For simulated ischemia
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experiments, the tissue was stimulated by direct contact with
punctate electrodes. The muscle preparation was lowered into
2,3-butanedione monoxime–free Ringer’s solution in a water-
jacketed tissue bath kept at 37°C, and partial pressure of oxy-
gen (PO2) was maintained above 600 mm Hg. The bathing
solution was replaced to remove residual 2,3-butanedione
monoxime before the experiment was begun. During the ini-
tial stabilization period, tissues were maintained unstretched
and field stimulated at 1 Hz with a 10-ms square wave pulse
by means of an isolated stimulator (Grass ST48). Transduced
muscle contraction was recorded with a Neomedix 8-channel
recorder (Neomedix Systems Pty Ltd, Warriewood, New
South Wales, Australia).
Contractile function assessment protocol. After 30 min-
utes of stabilization, each muscle strip was stretched incre-
mentally over 20 minutes to a length-developing maximum
force (L
max
). A further 30 minutes of stabilization ensued
after the tissues were superfused with fresh modified
Ringer’s solution. At the end of this period (t = 0), the fol-
lowing steady-state contractile function variables were
assessed: resting force (RF; in milligrams); developed force
(DF; in milligrams); contraction duration (CD; in millisec-
onds); time to peak tension (tPT; in milliseconds); and time
to 50% relaxation (tR50%; in milliseconds).
Approximately 3 to 5 pectinate trabeculae of appropriate
size were dissected from each right atrial appendage. When
the right atrial appendage sample was large enough, one ran-
domly selected trabecula was allocated to a time control
group that remained normoxic for the entire experimental
period (90 minutes). The remaining 2 to 3 trabeculae were
subjected to hypoxia or, in separate experiments, simulated
ischemia.
In the time control group trabeculae from 32 patients (20
men and 12 women; age, 62.2 ± 12.4 years) were maintained
in normoxic perfusate to determine muscle strip steady-state
contractile performance during the entire experimental peri-
od. Contractile function was measured at 4 time intervals (t =
0, 30, 60, and 90 minutes) and expressed relative to the initial
steady-state performance (t = 0 minutes).
In the hypoxia group, after initial contraction assessment
under normoxic conditions, trabeculae from 38 patients (24
men and 14 women; age, 62.0 ± 11.7 years) were subjected
to 30 minutes of hypoxia. Hypoxia was induced by reducing
PO2 to 45 ± 3 mm Hg in the Ringer’s solution by bubbling
with 95% N2/5% CO2, and tissues were electrically stimulat-
ed at 2 Hz.
In the simulated ischemia group, after normoxic assess-
ment, trabeculae from 20 patients (13 men and 7 women; age,
60.9 ± 10.3 years) were subjected to 30 minutes of ischemia,
which was simulated by impeding oxygen and metabolic sub-
strate delivery while permitting tissue metabolite accumula-
tion. The bath was sealed, and the Ringer’s solution was
drained to expose the muscle strip to superfusion with humid-
ified 95% N2/5% CO2 at 37°C. The tissue was paced at 2 Hz
by means of direct punctate electrode stimulation.
After hypoxia or ischemia, tissues were allowed normoxic
recovery paced at 1 Hz for 30 minutes, and postanoxic func-
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tion was measured for comparison with pre-stress contractile
function. Trabecular length under tension and weight was
determined at the end of each experiment to calculate cross-
sectional area. Cross-sectional area was calculated by divid-
ing muscle mass by the product of length and density, assum-
ing a cylindrical shape and a density of 1.06 mg/mm3.12
Tissues with a cross-sectional area of greater than 1.2 mm2
were excluded from the study because larger tissues are more
likely to have an anoxic core.13 DF and RF values were nor-
malized for cross-sectional area so that tension was not
affected by variable muscle size.
Statistical analysis. Because trabeculae from each patient
could not be considered morphologically identical, the mea-
sures for each variable of 3 to 4 trabeculae per patient were
analyzed individually, and the within-patient and between-
patient variance was calculated by PROC MIXED software
(SAS version 6.12; SAS Institute Inc, Cary, NC). Final values
per treatment group of patients are presented as means ± SD.
Differences in contractile function variables between treat-
ment groups were assessed by the 1-way analysis of variance
(ANOVA) and the Student-Newman-Keuls test for multiple
comparisons. Linear regression analysis was used to deter-
mine the correlations between age and post-stress recovery of
contractile function. Significant (P < .05) clinical predictors
of recovery of contractile function were identified by univari-
ate analysis, which was performed with 1-way ANOVA, lin-
ear regression, and a t test where appropriate. These predic-
tors were then entered into a multivariate stepwise forward
linear regression model, with contractile function as the out-
come variable. The order in which variables were entered was
alternated to determine the optimum predictive model.
Analyses were performed by use of SAS version 6.12.
Results
Baseline characteristics and contractile function.
Average patient age was similar for the normoxic (62.2 ±
12.4 years, n = 32), hypoxic (62.0 ± 11.7 years, n = 38),
and ischemic (60.9 ± 10.3 years, n = 20) treatment series
(1-way ANOVA, P = .69). Tissues from male and female
subjects were similarly distributed throughout the groups
(χ2 = 0.545, P = .76). The physical and the baseline
steady-state contractile function characteristics of pecti-
nate trabeculae from the 58 patients are summarized in
Table I. Steady-state contractile performance assessed
immediately before induction of the hypoxic or ischemic
stress periods was determined for each trabecula. Length
at L
max
, blotted weight, cross-sectional area, and all mea-
sured variables of normoxic contractile function were
similar for all the age groups.
In the normoxic control group (n = 32), compared
with DF at 0 minutes, there was a decrease in relative
DF of 1.8% at 30 minutes, 8.8% by 60 minutes, and
21.5% by the end of the 90 minutes required for the pro-
tocol. No significant correlation existed between age
and contractile performance of the normoxic controls
after 90 minutes of steady-state contraction (Table II).
In accordance with the methods of Keon,12 and
Labow,13 and their colleagues, the effect of initial base-
line DF on the stability of the preparation over the
experimental period was examined. Trabeculae produc-
ing a DF greater than a threshold DF of 800 mg (n = 24;
mean age, 64.5 ± 11.7 years) were compared with those
producing less than 800 mg (n = 8; mean age, 57.9 ± 8.7
years). No significant difference was found in the grad-
ual decline in DF over 90 minutes between those strips
with an initial DF greater than 800 mg (82.3% ± 11.3%)
and those with less than 800 mg (76.5% ± 10.7%).
Recovery of contractile function after hypoxia.
Functional recovery results were grouped according to
patient age. A senescent group, composed of trabeculae
from patients aged 70 to 89 years, was selected on the
basis of increased mortality risk for cardiac operations
in patients over 70 years old.1 The next youngest
decade was designated as the intermediate group
Table I. Baseline normoxic contractile function measures of pectinate trabeculae
Age group
Group 34-59 y (n = 21) 60-69 y (n = 21) 70-89 y (n = 16) P value
Age (y) 48.4 ± 8.2 64.9 ± 2.7 74.8 ± 4 <.0001
L
max
(mm) 7.19 ± 2.1 6.49 ± 1.3 7.14 ± 2.1 .4
Weight (mg) 6.17 ± 2.7 5.68 ± 1.8 5.84 ± 1.2 .7
CSA (mm2) 0.80 ± 0.2 0.83 ± 0.18 0.81 ± 0.2 .8
DF (mg) 1140 ± 405 1080 ± 301 1187 ± 352 .7
RF (mg) 266.1 ± 101 302.9 ± 137 322.4 ± 111 .4
tPT (ms) 90.1 ± 12.3 91.2 ± 9.1 89.5 ± 10 .9
tR50% (ms) 100.9 ± 16.9 95.4 ± 18.7 99.9 ± 20.8 .6
CD (ms) 191.0 ± 23.3 186.6 ± 23.3 189.3 ± 27.6 .8
From all treatment groups (n = 58), values are expressed as means ± SD. Age group contrasts were made by 1-way ANOVA. DF, Developed force; RF, resting force;
tPT, time to peak tension; tR50%, time to 50% relaxation; CD, contract duration; CSA, cross-sectional area; Lmax, length developing maximum force.
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(60–69 years). The third group consisted of tissue from
patients aged 34 to 59 years.
Contractile function before and after 30 minutes of
hypoxia was recorded in each trabecula (n = 73) from
38 patients, and the effect of hypoxia was assessed. For
the whole group, there was a significant reduction in
DF (54.4% ± 22.2%), tPT (87.7% ± 9.8%), tR50%
(85.6% ± 12.3%), and CD (86.6% ± 10.5%; for each
variable, P < .0001). Posthypoxic RF (308 ± 154 mg)
was not statistically significant (P = .3) compared with
prehypoxic RF (285 ± 129 mg). The resultant modest
reduction of posthypoxic contractile variables indicates
that the hypoxic stress used was of intermediate sever-
ity, produced only a mild hypoxic contracture, and per-
mitted post-stress recovery of contraction. Fig 1, A,
shows that the aged (70-89 years) and intermediate (60-
69 years) groups had significantly less posthypoxic
recovery of DF than the youngest group (34-59 years).
No significant difference was observed among the 3
age groups for any other variable (Table II).
Recovery of contractile function after simulated
ischemia. Contractile function before and after
ischemia was recorded in each trabecula (n = 35) from
20 patients. For the whole group, simulated ischemia
significantly lowered DF to 52.4% ± 18.7% of pre-
ischemic performance (P < .0001) but did not signifi-
cantly affect RF (before, 282 ± 21 mg; after, 262 ± 93
mg; P = .3), tPT (before, 91.4 ± 9.8 ms; after, 82.7 ±
10.7 ms; P = .6), tR50% (before, 89.8 ± 12.1 ms; after,
81.3 ± 11.6 ms; P = .5), and CD (before, 181.2 ± 18.3
ms; after, 164 ± 16.9 ms; P = .3).
The groups of 70- to 89-year-old and 60– to 69-year-
old subjects had significantly less recovery of DF than
the group of 34- to 60-year-old subjects (P = .007; Fig
1, B). As seen after hypoxia, no age-related differences
were observed for other contractile variables (Table II).
Linear regression analysis indicated there was a highly
significant linear relationship between the reduced
postischemic recovery of DF and increased age (r2 =
0.54, P = .0002; Fig 1, C).
Analysis of poststress recovery of contraction and
patient clinical variables. Individual patient characteris-
tics, assessed before or during the operation, were first
compared as univariate predictors of recovery. Of 21 vari-
ables (Table III), age (P = .01), hypertension (P = .01),
prior treatment with nitrates (P = .02), and Ca2+ channel
Table II. Recovery of pectinate trabeculae contractile function after 30 minutes of either hypoxia or simulated
ischemia expressed as a percentage of prehypoxic or preischemic values, respectively
34-59 y 60-69 y 70-89 y P value
Control n = 12 n = 10 n = 10
Age 49.1 ± 8.3 65.0 ± 2.8 75.2 ± 4.7 <.0001
DF 82.6 ± 20.4 74.3 ± 16.6 77.7 ± 7.6 .2
RF 96.1 ± 26.6 69.9 ± 31.3 81.3 ± 24.7 .8
tPT 96.2 ± 10.0 90.9 ± 12.3 97.0 ± 6.0 .2
tR50% 89.9 ± 11.7 95.0 ± 13.9 90.7 ± 11.3 .1
CD 92.6 ± 9.7 92.6 ± 32.4 93.2 ± 6.9 .2
Hypoxia n = 15 n = 12 n = 11
Age 50 ± 7.7 65 ± 3.4 75 ± 3.3 <.0001
DF 66.4 ± 19.7 44.9 ± 19.0* 48.5 ± 20.2† .02
RF 95.0 ± 46.5 98.1 ± 30.0 147.2 ± 109 .2
tPT 87.2 ± 9.7 86.5 ± 10.7 92.5 ± 16.9 .5
tR50% 83.5 ± 11.2 88.1 ± 13.1 85.9 ± 12.6 .3
CD 85.0 ± 8.9 86.8 ± 9.7 88.8 ± 14.3 .8
Ischemia n = 6 n = 9 n = 5
Age 44.5 ± 10.0 64.4 ± 3.3 74.2 ± 3.3 <.0001
DF 68.2 ± 10.8 51.1 ± 15.6‡ 35.7 ± 16.8§ .01
RF 82.6 ± 25.5 100.2 ± 21.6 92.9 ± 25.5 .5
tPT 89.5 ± 9.8 91.1 ± 11.7 85.5 ± 15.4 .8
tR50% 94.3 ± 19.3 101.0 ± 28.2 83.8 ± 12.5 .8
CD 91.0 ± 8.3 95.2 ± 12.0 84.8 ± 12.3 .6
Values are given as means ± SD. The control group was time matched and consisted of muscle strips maintained under normoxic conditions throughout the entire
90-minute study period. Time-matched control data are the value measured at 90 minutes expressed as a percentage of the value at 30 minutes, corresponding to the
time of prehypoxic, posthypoxic, and postischemic assessments. Age group contrasts were made by 1-way ANOVA and the Student-Newman-Keuls test for multiple
comparisons. For abbreviations, see Table I.
*P = .02 versus 34- to 59-year-old group.
†P = .02 versus 34- to 59-year-old group.
‡P = .03 versus 34- to 59-year-old group.
§P = .01 versus 34- to 59-year-old group.
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antagonists (P = .01) were significant factors associated
with reduced recovery of DF after either hypoxia or sim-
ulated ischemia. However, when multivariate stepwise
forward linear regression was performed, only age
(parameter estimate = –0.7324 ± 0.213, P = .001) and
hypertension (parameter estimate = –11.0159 ± 4.97, P =
.03) were significant independent predictors of dimin-
ished recovery of DF after hypoxic or ischemic stress.
Multivariate linear regression of other contractile func-
tion variables (RF, tPT, tR50%, and CD) indicated that age
and hypertension had no predictive effect on poststress
outcome. However, of all the clinical variables, multi-
variate linear regression revealed that only the prior treat-
ment with angiotensin-converting enzyme inhibitor had
an effect on post-stress CD (angiotensin-converting
enzyme inhibitor group CD = 79.5 ± 8.3 ms, n = 13; with-
out CD = 89.6 ± 9.4 ms, n = 45; parameter estimate =
–2.2383 ± 2.46; P = .001). This effect on CD reflected the
prevalence of heart failure in these patients.
There were no in-hospital deaths in any of the
groups. Predictably, the incidence of postoperative atri-
al fibrillation increased with age (34-59 years = 5/21;
60-69 years = 12/20; 70-89 years = 2/17; P = .004, χ2
test). However, postoperative inotrope use was unrelat-
ed to age (34-59 years = 0/21; 60-69 years = 4/20; 70-
89 years = 3/17; P = .1, χ2 test).
Discussion
The present study, using isolated human atrial pecti-
nate trabeculae in vitro, has shown that after ischemia
or hypoxia, the older human atrial myocardium has a
significantly reduced capacity to recover contractile
performance compared with that of individuals aged
less than 60 years. For both hypoxia and ischemia, we
observed that, compared with time-matched controls,
the recovery of DF was inversely related to the age of
the subject. These present findings in human subjects
are supported by several previous reports in animal
models of an association between aging and reduced
postischemic recovery of systolic function.4-7 The pres-
ent data demonstrate that senescent human myocardi-
um is intrinsically more sensitive to the stress imposed
by reversible hypoxia or ischemia in vitro. Thus, we
provide a myocardial basis for the clinical association
between age and increased rates of mortality and com-
plications after coronary artery bypass grafting1,2
involving periods of cardiac hypoxia and ischemia.
Isolated human atrial pectinate muscle model.
Several studies have used the isolated human atrial
pectinate muscle model to assess human myocardial
performance in vitro and thus eliminate extrapolation
from animal studies.12,13 We assessed the stability of
this model for use in the present study by maintaining
contracting muscle strips in normoxic conditions. DF
was found to decrease gradually by 21.5% after 90
minutes, which is similar to previous reports.12,13
Despite this decline, contractile function under nor-
moxic conditions did not differ between the age
groups, even after 90 minutes. Thus, the age-associated
differences we have observed appear to not be related
to deterioration of baseline myocardial performance
but rather to a decline with increasing age of intrinsic
myocardial tolerance to stress. The implication for car-
Fig 1. The recovery of trabecular contractile DF after 30 min-
utes of hypoxia (A) or simulated ischemia (B) is expressed as
a percentage of pre-stress DF in 3 age groups. Panel C shows
the percentage recovery of the DF achieved after simulated
ischemia or hypoxia plotted against age as a linear function
(n = 58, r2 = 0.52, P = .0002).
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diac surgery in elderly patients is that although preop-
erative myocardial performance may appear to be ade-
quate to withstand the overall stress of surgery, the abil-
ity to recover function after cardioplegia or episodes of
perioperative hypoxia may be severely reduced. The
importance of age as a major influence on myocardial
susceptibility to hypoxic and ischemic stress is high-
lighted by the absence of interaction between age and
other factors (Table III). The only other significant pre-
dictor identified was hypertension. This might reflect
the higher level of sympathetic tone14 that has been
described in hypertension and the perturbations to the
intracellular calcium homeostasis of myocytes9 that
may reduce the resistance of the myocardium to stress.
Table III. Univariate analysis of post-stress recovery of trabecular DF
Variable Category DF (% recovery) n P value
Age (y) 34-59 66.9 ± 17.9 21 .01
60-69 49.0 ± 17.9 21
70-89 43.5 ± 18.0 16
Sex Male 53.8 ± 19.5 37 .9
Female 54.3 ± 22.4 21
Experiment type Hypoxia 53.3 ± 23.4 38 .4
Ischemia 54.3 ± 16.1 20
Hypertension Yes 46.1 ± 20.1 28 .01
No 61.3 ± 18.1 30
Hypercholesterolemia Yes 52.6 ± 18.6 24 .8
No 55.0 ± 21.5 34
Diabetes mellitus Yes 52.3 ± 23.9 12 .4
No 54.4 ± 19.7 46
Smoking history Yes 59.9 ± 18.0 28 .1
No 52.2 ± 22.4 30
CAD family history Yes 57.2 ± 24.3 17 .6
No 52.6 ± 18.5 41
Angina None 54.3 ± 20.6 8 .8
Stable 55.4 ± 20.7 37
Unstable 49.7 ± 5.7 13
CHF Yes 53.1 ± 23.7 9 .8
No 54.1 ± 20.3 49
No. of vessels grafted 2 56.1 ± 20.6 17 .5
3 53.8 ± 20.4 36
4 47.4 ± 20.6 5
Digoxin Yes 63.9 ± 5.4 4 .5
No 53.2 ± 20.5 54
Nitrates Yes 47.9 ± 21.4 32 .02
No 61.5 ± 15.8 26
Diuretics Yes 50.8 ± 24.1 13 .8
No 54.9 ± 19.4 45
Ca2+ channel antagonist Yes 51.0 ± 22.5 25 .01
No 56.2 ± 18.4 33
β-Adrenergic receptor antagonist Yes 54.5 ± 15.9 35 .3
No 53.2 ± 25.9 23
ACE inhibitor Yes 45.2 ± 23.4 13 .6
No 56.5 ± 18.7 45
Aspirin Yes 51.1 ± 23.0 30 .2
No 57.0 ± 16.9 28
Anticoagulant Yes 54.5 ± 16.9 11 .8
No 53.8 ± 21.2 47
Cardioversion Yes 54.9 ± 21.8 12 .9
No 53.7 ± 20.3 46
Surgeon A 50.5 ± 20.6 17 .6
B 60.1 ± 20.4 12
C 54.4 ± 20.7 18
D 51.9 ± 20.5 11
DF, Developed force; CAD, coronary artery disease; CHF, congenstive heart failure; ACE, angiotensin-converting enzyme.
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One clear limitation of the present model is the use
of atrial rather than ventricular muscle. Not only is
access to healthy human myocardial tissue for study
purposes rare, but also the limited size of ventricular
biopsy samples precludes conventional force transduc-
tion experiments in ventricular myocardium. The
human atrial trabecular preparation has been validated
and well accepted in the study of pharmacologic
agents.13,15 There are clear structural and functional
differences between atrial and ventricular tissue,16
which limit the use of atrial tissue as an experimental
surrogate for ventricular myocardium. However, atrial
trabeculae may still be a valid indicator of the effect of
aging on the intrinsic response of myocardial tissue to
ischemic or hypoxic stress. A confounding factor with
the use of this model in the present study of aging
could be the presence of myocardial disease in the atri-
al appendage. A substantial effect of myocardial dis-
ease is unlikely because this study used only atrial
appendages from patients free of overt right heart fail-
ure and with normal macroscopic appearance, a find-
ing confirmed in early experiments by histologic
examination. More important, no correlation was
observed between recovery of atrial strip function after
hypoxia and ischemia and any markers of myocardial
disease, such as congestive heart failure or the number
of diseased vessels (Table III).
Potential mechanisms of age-associated deficits in
postischemic cardiac function. Ischemia of the
myocardium leads to a switch from aerobic to anaero-
bic metabolism, with consequent depletion of high-
energy phosphates, accumulation of lactate, acidosis,
and loss of intracellular ionic homeostasis.6,11,17,18
Reperfusion results in augmented oxygen-derived free
radical production, cytosolic and mitochondrial calci-
um overload, and, in cases of severe ischemia, sar-
colemmal membrane disruption.18-20 These adverse
events are exaggerated in the senescent myocardium,
particularly calcium overload6,9-11,20 and free radical
release,21-24 with devastating consequences on ion-
dependent enzymes, intracellular signaling, and energy
production.6,18-25
Most adenosine triphosphate required for cellular
activity is produced in the mitochondrial respiratory
chain by oxidative phosphorylation, and key subunits
of this system are encoded by mitochondrial DNA.26
An increase in the abundance of mutant mitochondrial
DNA (together with an increase in nuclear somatic
mutations) found with advanced age has been implicat-
ed in age-associated deficits in mitochondrial function,
mainly because of altered free radical activity that leads
to the destruction of cellular membrane lipids, proteins,
and DNA.21,23,24,27 Of the various mitochondrial
enzymes reported to exhibit altered function in
aging,10,17,21-25,27 the most crucial is cytochrome c oxi-
dase.23-25 This is the terminal enzyme of the respirato-
ry chain essential for the transfer of electrons to molec-
ular oxygen, and 3 of its largest subunits are encoded
by mitochondrial DNA, which are synthesized in mito-
chondria.26 Cytochrome c oxidase deficiency has been
found to be associated with several overt mitochondri-
al diseases involving severe metabolic impairment,28
and it has also been reported to be markedly dimin-
ished in cardiac myocytes free from apparent disease in
human beings aged 50 to 97 years compared with those
aged 14 to 50 years.25 However, it is evident that the
age-associated deficits in myocardial function mainly
shown in animal studies and usually apparent only after
superimposition of nonphysiologic stress are multifac-
torial and require detailed molecular investigation in
human subjects. Indeed, the biologic significance of
mitochondrial DNA mutations and other mitochondrial
deficits in senescent human myocardium remains con-
troversial.
In conclusion, the present study in an in vitro model
of human atrial pectinate trabeculae has shown that
atrial myocardium from elderly subjects has a signif-
icantly reduced capacity to recover systolic force after
a hypoxic or ischemic stress. Although under nor-
moxic conditions no significant difference was
observed in the contractile performance between dif-
ferent age groups, after stress, the recovery of DF was
inversely related to the age of the patient undergoing
coronary artery bypass grafting. This underlying dif-
ference between elderly and younger myocardium has
implications for myocardial management during
surgery in elderly patients. The intrinsic molecular
mechanisms responsible for these age-associated
responses require direct investigation, and their defi-
nition is critical to design age-specific surgical and
pharmacologic therapy.
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